Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for Privia Health (PRVA) over the last 6 years, with Q2 2025 value amounting to $6.1 million.

  • Privia Health's Gains from Investment Securities changed N/A to $6.1 million in Q2 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year decrease of 634.51%. This contributed to the annual value of $5.0 million for FY2024, which is 10765.1% up from last year.
  • Per Privia Health's latest filing, its Gains from Investment Securities stood at $6.1 million for Q2 2025.
  • Privia Health's Gains from Investment Securities' 5-year high stood at $9.9 million during Q3 2022, with a 5-year trough of -$9.1 million in Q4 2022.
  • Moreover, its 5-year median value for Gains from Investment Securities was $331000.0 (2023), whereas its average is $1.3 million.
  • Over the last 5 years, Privia Health's Gains from Investment Securities had its largest YoY gain of 19850000.0% in 2022, and its largest YoY loss of 26848.35% in 2022.
  • Privia Health's Gains from Investment Securities (Quarter) stood at $5.4 million in 2021, then tumbled by 268.48% to -$9.1 million in 2022, then skyrocketed by 112.9% to $1.2 million in 2023, then plummeted by 98.72% to $15000.0 in 2024, then soared by 40460.0% to $6.1 million in 2025.
  • Its last three reported values are $6.1 million in Q2 2025, -$313000.0 for Q1 2025, and $15000.0 during Q4 2024.